According to Pieris Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is C$28 Million. In 2022 the company made a revenue of C$35.14 Million a decrease over the revenue in the year 2021 that were of C$40.04 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.